lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with lauric acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Magdalou J et al. | Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxide hydrolases and UDP-glucuronosyltransferases in rat liver. | 1988 | Biochem. Pharmacol. | pmid:2840913 |
Amet Y et al. | Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. | 1995 | Biochem. Pharmacol. | pmid:8615855 |
Williams DE et al. | Sex differences in cytochrome P-450 isozyme composition and activity in kidney microsomes of mature rainbow trout. | 1986 | Biochem. Pharmacol. | pmid:3718543 |
Pons N et al. | Interaction of polyhalogenated compounds of appropriate configuration with mammalian or bacterial CYP enzymes. Increased bilirubin and uroporphyrinogen oxidation in vitro. | 2003 | Biochem. Pharmacol. | pmid:12907239 |
Ronis MJ et al. | Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). | 1994 | Biochem. Pharmacol. | pmid:7986207 |
Sharma R et al. | Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. | 1988 | Biochem. Pharmacol. | pmid:3355594 |
Past MR and Cook DE | Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450. | 1982 | Biochem. Pharmacol. | pmid:7150359 |
De Matteis F et al. | Peroxidase-like activity of uncoupled cytochrome P450: studies with bilirubin and toxicological implications of uncoupling. | 2012 | Biochem. Pharmacol. | pmid:22564776 |
Bains SK et al. | Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. | 1985 | Biochem. Pharmacol. | pmid:3929789 |
Hornung B et al. | Medium chain length fatty acids stimulate triacylglycerol synthesis in tissue culture cells. | 1992 | Biochem. Pharmacol. | pmid:1739406 |
Knickle LC et al. | The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid. | 1992 | Biochem. Pharmacol. | pmid:1380810 |
RodrÃguez-Penas D et al. | Aliskiren affects fatty-acid uptake and lipid-related genes in rodent and human cardiomyocytes. | 2011 | Biochem. Pharmacol. | pmid:21640714 |
Sivapathasundaram S et al. | A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. | 2001 | Biochem. Pharmacol. | pmid:11585060 |
Amet Y et al. | Cytochrome P450 4A and 2E1 expression in human kidney microsomes. | 1997 | Biochem. Pharmacol. | pmid:9113097 |
Okita RT et al. | Lauric acid hydroxylation in human liver and kidney cortex microsomes. | 1979 | Biochem. Pharmacol. | pmid:533546 |
Hvattum E et al. | Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver. | 1991 Mar 15-Apr 1 | Biochem. Pharmacol. | pmid:1672593 |
Kocarek TA and Feller DR | Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes. | 1989 | Biochem. Pharmacol. | pmid:2597188 |
Kitagawa S et al. | Effects of alkyl gallates on P-glycoprotein function. | 2005 | Biochem. Pharmacol. | pmid:16139251 |
Pham MA et al. | Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. | 1989 | Biochem. Pharmacol. | pmid:2500129 |
Raza H and Levine WG | Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes. | 1987 | Biochem. Pharmacol. | pmid:3103631 |